Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification
- PMID: 29034013
- PMCID: PMC5579802
- DOI: 10.3400/avd.ra.17-00006
Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification
Abstract
Particularly in patients with hemodialysis, cardiovascular mortality rate is extremely high. Polyvascular diseases develop at an early stage of chronic kidney disease (CKD). Pathophysiology includes insulin resistance and/or imbalance between nitric oxide (NO) and endothelin bioavailability as well as oxidative stress. The understanding in pathophysiology of vascular calcification and strategic treatment is a critical issue to achieve favorable outcome for the patients with CKD. In this article, we aim to review the cardiovascular disease for the patients with CKD with a particular emphasis on the clinical aspects of polyvascular disease. Finally, we address to detect microcirculatory impairment and eradicate vascular calcification as early as possible prior to renal replacement therapy. (This is a translation of Jpn J Vasc Surg 2016; 25: 359-365.).
Keywords: PAD; cardiovascular events; coronary; hemodialysis.
Conflict of interest statement
The author received lecture fees from Bayer Yakuhin, Ltd., Kaneka Corporation, and Chugai Pharmaceutical Co., Ltd. There is no other conflict of interest, involving relatives.
Figures
Similar articles
-
Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification.J Cardiovasc Dev Dis. 2023 May 10;10(5):207. doi: 10.3390/jcdd10050207. J Cardiovasc Dev Dis. 2023. PMID: 37233174 Free PMC article. Review.
-
Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.J Hypertens. 2017 Feb;35(2):376-384. doi: 10.1097/HJH.0000000000001161. J Hypertens. 2017. PMID: 28005706
-
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].Clin Calcium. 2015 May;25(5):645-53. Clin Calcium. 2015. PMID: 25926567 Review. Japanese.
-
Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.J Ren Nutr. 2006 Apr;16(2):100-18. doi: 10.1053/j.jrn.2006.01.006. J Ren Nutr. 2006. PMID: 16567266 Review.
-
Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.Adv Clin Chem. 2008;46:217-62. doi: 10.1016/s0065-2423(08)00406-x. Adv Clin Chem. 2008. PMID: 19004191 Review.
Cited by
-
Impact of Chronic Kidney Disease on Clinical Outcomes during Hospitalization and Five-Year Follow-Up after Coronary Artery Bypass Grafting.Crit Care Res Pract. 2023 Sep 26;2023:9364913. doi: 10.1155/2023/9364913. eCollection 2023. Crit Care Res Pract. 2023. PMID: 37795473 Free PMC article.
-
Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia.Front Med (Lausanne). 2023 May 19;10:1086359. doi: 10.3389/fmed.2023.1086359. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37275357 Free PMC article.
-
Presepsin Level Correlates with the Development of Moderate Coronary Artery Calcifications in Hemodialysis Patients: A Preliminary Cross-Section Design Study.Risk Manag Healthc Policy. 2020 Aug 3;13:999-1006. doi: 10.2147/RMHP.S262058. eCollection 2020. Risk Manag Healthc Policy. 2020. PMID: 32821182 Free PMC article.
-
The Characteristics of Dialysis Membranes: Benefits of the AN69 Membrane in Hemodialysis Patients.J Clin Med. 2023 Jan 31;12(3):1123. doi: 10.3390/jcm12031123. J Clin Med. 2023. PMID: 36769771 Free PMC article. Review.
-
Coronary Artery Bypass Surgery in End-Stage Renal Disease Patients.Ann Vasc Dis. 2017 Jun 25;10(2):79-87. doi: 10.3400/avd.ra.17-00024. Ann Vasc Dis. 2017. PMID: 29034031 Free PMC article. Review.
References
-
- Kobayashi S, Maesato K, Moriya H, et al. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 275-80. - PubMed
-
- Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-69. - PubMed
-
- Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305. - PubMed
-
- Ohtake T, Kobayashi S, Oka M, et al. Lanthanum carbonate delays the progression of coronary artery calcification compared with calcium-based phosphate binders in paients on hemodialysis: a pilot study. J Cardiovasc Pharmacol Ther 2013; 18: 439-46. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources